Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.38 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.36 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30634609 | 0.91 | MAPK1 (0.46) | LGALS8 | |
| SCHEMBL30587044 | 0.91 | MAPK1 (0.46) | LGALS8 | |
| SCHEMBL26350758 | 0.88 | MAPK1 (0.43) | LGALS8 | |
| SCHEMBL17448300 | 0.85 | TACR1 (0.38) | HTT | |
| SCHEMBL17640891 | 0.85 | TACR1 (0.38) | HTT | |
| SCHEMBL16693722 | 0.85 | TACR1 (0.38) | HTT | |
| SCHEMBL17448328 | 0.85 | TACR1 (0.38) | HTT | |
| SCHEMBL20510352 | 0.84 | LGALS8 (0.42) | MAOBSLC6A2LGALS8SLC5A1SLC5A2 | |
| SCHEMBL30391620 | 0.83 | HTT (0.46) | MAOBLGALS8HTT | |
| SCHEMBL30891325 | 0.83 | HTT (0.46) | MAOBLGALS8HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303618-A1 | TRIPTOLIDE CONJUGATES AND USES THEREOF | REYOUNG CORPORATION (US) | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303618-A1 | TRIPTOLIDE CONJUGATES AND USES THEREOF | TLR9, XIAP, ENPP2 | MAOB 1900/4885SLC6A2 3027/4885LGALS8 64/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.